(Q34121289)
Statements
Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study (English)
Santos Castañeda
scientific article
No description defined